INNOCHEMBIO - Innovative Chemistry and Biotechnology for a Sustainable Future
The Marie Skłodowska-Curie Actions (MSCA) COFUND programme INNOCHEMBIO was funded by the European Commission in 2025. INNOCHEMBIO funding will co-finance 15 PhD positions, for which the application process in the first call will start on the 1st of July in 2025.
The hosting institution Department of Chemistry and Biotechnology (DCB) at Tallinn University of Technology (TalTech) combines three divisions - Chemistry, Gene Technology and Biomedicine, and Food and Biotechnology. DCB is developing solutions to the great challenges of the 21st century – climate change, environmental protection, carbon neutrality, renewable energy, and biodiversity conservation. DCB hosts the second biggest PhD programme in TalTech with nearly a hundred enrolled students.
Out of the 12 PhD candidates employed by TalTech, 11 will be working at the Department of Chemistry and Biotechnology (DCB). In addition to DCB, one position will be hosted at the Department of Cybernetics in an interdisciplinary laboratory working on cardiac physiology using integrated approaches from biology, chemistry, physics, and applied mathematics.
INNOCHEMBIO has 1 implementing partner - National Institute of Chemical Physics and Biophysics (NICPB). NICPB is a public research institution that conducts both fundamental and applied research, developing novel directions in fields from material sciences to informatics. One of its key missions is to educate new generations of scientists in these areas. For INNOCHEMBIO, NICPB houses the Laboratory of Environmental Toxicology and several laboratories focused on fundamental research in NMR technologies with expertise dating back decades. TalTech and NICPB maintain several close partnerships that go beyond research cooperation. Importantly, the PhD training activities conducted by NICPB are funded through TalTech. Three of the INNOCHEMBIO PhD candidates will be employed by NICPB.
INNOCHEMBIO has 19 associate partners from 11 European countries, involving both academia and industry. The partners are the following: Optibrium Inc., Karlsruhe Institute of Technology, The University of Warsaw, Institut national de recherche pour l’agriculture, l’alimentation et l’environnement, University of Helsinki, The University of Amsterdam, Université Grenoble Alpes, SafePAS, Jagiellonian University in Krakow, University of Geneva, University of Ljubljana, Aix-Marseille Université, Aarhus University, Universite de Liege, The University of Eastern Finland, University of Birmingham, AS TFTAK, AIÖ Tech OÜ, Icosagen AS.
SUPPORTED BY MSCA COFUND ACTION
The INNOCHEMBIO programme has received funding from the European Union’s COFUND action, a part of the Marie Skłodowska-Curie Actions Program within the European Commission MSCA framework.
INNOCHEMBIO Grant agreement ID: 101217295
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or MSCA. Neither the European Union nor the granting authority can be held responsible for them.